found that high EGFR expression drives tumor proliferation and is associated with poor prognosis.[38] These findings suggest that breast cancer and renal cell carcinoma may share certain key proliferation signaling pathways, providing insights for cross‐cancer molecular mechanism studies. Here, EGFR is linked to breast carcinoma.